ABSTRACT
background Despite active case-finding (ACF) identifying more presumptive and confirmed TB cases, high pre-diagnostic loss to follow-up (PDLFU) among presumptive TB cases referred for diagnostic test remains a concern. We aimed to quantify the PDLFU, and identify the barriers and enablers in undergoing a diagnostic evaluation in an ACF program implemented in 1.02 million rural population in the Samastipur district of Bihar, India.
methods During their routine work, Accredited Social Health Activists (ASHA, a community health worker or CHW), informal providers, and community laypersons identified people at risk of TB, and referred them to the program. A field coordinator (FC) screened them for TB symptoms at the patient’s home. The identified presumptive TB cases were accompanied by the CHW to a designated government facility for diagnostics. Those with a confirmed TB diagnosis were put on treatment by the CHW and followed-up till treatment completion. All services were provided free of cost and patients were supported throughout the care pathway, including a transport allowance. We analyzed programmatically collected data, conducted in-depth interviews with patients, and focus group discussions with the CHWs and FCs in an explanatory mixed-methods design.
results A total of 11146 presumptive TB cases were identified from January 2018 to December 2018, out of which 4912 (44.1%) underwent a diagnostic evaluation. The key enablers were CHW accompaniment and support in addition to the free TB services in the public sector. The major barriers identified were transport challenges, deficient family and health provider support, and poor services in the public system.
conclusion If we are to find missing cases, the health system needs urgent reform, and diagnostic services need to be patient-centric. A strong patient support system engaging all stakeholders and involvement of CHWs in routine TB care is an effective solution.
STRENGTHS AND LIMITATIONS OF THIS STUDY
First such study to explore the reasons for pre-diagnostic loss to follow-up
A mixed-method design including the views of both patients and community health workers
Uses operational data from a routine programmatic setting at an NGO site
No record of the actual number of people screened intuitively before being referred to the program.
No record of patients accessing diagnostics in private sector and those completing the diagnostic process.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This project was supported by the Stop TB Partnership’s TB REACH initiative and was funded by the Government of Canada and the Bill & Melinda Gates Foundation. Manish Bhardwaj and Dyuti Sen are supported by a Grand Challenges Explorations grant number OPP1190735 and OPP1190905 respectively from the Bill & Melinda Gates Foundation. The training program, within which this paper was developed, was funded by the Department for International Development (DFID), UK. No funders had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Author Declarations
All relevant ethical guidelines have been followed and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
Any clinical trials involved have been registered with an ICMJE-approved registry such as ClinicalTrials.gov and the trial ID is included in the manuscript.
Not Applicable
I have followed all appropriate research reporting guidelines and uploaded the relevant Equator, ICMJE or other checklist(s) as supplementary files, if applicable.
Yes
Data Availability
The deidentified data used in the study is available from the corresponding author on reasonable request. It contains information on patient demographics and characteristics, screening criteria, diagnostic test used, and final diagnosis. There is no additional data available beyond that.
